These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 31980182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis.
    Chen L, Zhan CZ, Wang T, You H, Yao R.
    Yonsei Med J; 2020 Jan; 61(1):20-29. PubMed ID: 31887796
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK.
    Oncotarget; 2015 Jun 20; 6(17):15035-49. PubMed ID: 25909227
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
    Sun X, Li B, Xie B, Xu Z, Chang G, Tao Y, Zhang Y, Chang S, Wang Y, Yu D, Xie Y, Li T, Wang H, Chen G, Hu L, Hou J, Zhang Y, Xiao W, Gao L, Shi J, Zhu W.
    Cell Death Dis; 2017 Oct 12; 8(10):e3111. PubMed ID: 29022919
    [Abstract] [Full Text] [Related]

  • 11. Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway.
    Hu K, Li B, Ma R, Yi H, Xu Z, Peng Y, Yu D, Wu H, Cheng T, Lu Y, Zhang Y, Wei R, Yang G, Wu X, Zhu W, Shi J.
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr 15; 53(5):575-583. PubMed ID: 33821934
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway.
    Wu C, Chen S, Wu Z, Xue J, Zhang W, Wang S, Xindong Zhao, Wu S.
    J Cancer Res Clin Oncol; 2024 Feb 21; 150(2):98. PubMed ID: 38381215
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line.
    Han J, Tang Y, Zhong M, Wu W.
    Mol Med Rep; 2019 Dec 21; 20(6):5064-5074. PubMed ID: 31638226
    [Abstract] [Full Text] [Related]

  • 15. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ, Xia ZG, Wang AH, Wang WF, Liu ZY, Chen LY, Li JM.
    Ann Hematol; 2013 Oct 21; 92(10):1351-8. PubMed ID: 23636313
    [Abstract] [Full Text] [Related]

  • 16. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S, Wang W, Wang H, Zhu Y, Lei C.
    BMC Cancer; 2019 Mar 07; 19(1):204. PubMed ID: 30845932
    [Abstract] [Full Text] [Related]

  • 17. Curcumin attenuates cardiomyocyte hypertrophy induced by high glucose and insulin via the PPARγ/Akt/NO signaling pathway.
    Chen R, Peng X, Du W, Wu Y, Huang B, Xue L, Wu Q, Qiu H, Jiang Q.
    Diabetes Res Clin Pract; 2015 May 07; 108(2):235-42. PubMed ID: 25765666
    [Abstract] [Full Text] [Related]

  • 18. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Zhao G, Han X, Zheng S, Li Z, Sha Y, Ni J, Sun Z, Qiao S, Song Z.
    Oncol Rep; 2016 Feb 07; 35(2):1065-74. PubMed ID: 26573768
    [Abstract] [Full Text] [Related]

  • 19. ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.
    Mao Y, Xu L, Wang J, Zhang L, Hou N, Xu J, Wang L, Yang S, Chen Y, Xiong L, Zhu J, Fan W, Xu J.
    Biofactors; 2019 May 07; 45(3):416-426. PubMed ID: 30801854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.